The significance of GlgE as a new target for tuberculosis

Drug News and Perspectives

Volumn 23, Issue 10, 2010, Pages 619-624

  Kalscheuer, Rainer ^a   Jacobs Jr , William R ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; GLUCAN; MALTOSE 1 PHOSPHATE; PROTEIN GLGE; SUGAR PHOSPHATE; TRANSFERASE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; GLUCOSYLTRANSFERASE; MALTOSYLTRANSFERASE;

BACTERIAL STRAIN; DNA DAMAGE; DRUG TARGETING; ENZYME INACTIVATION; HUMAN; INDUSTRIALIZATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANDEMIC; REVIEW; TUBERCULOSIS; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFECT; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GLUCOSYLTRANSFERASES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79954442657     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2010.23.10.1534855     Document Type: Review

References (21)

1. Dye, C. Global epidemiology of tuberculosis. Lancet 2006, 367(9514): 938-40.
2. Lalloo, U.G., Ambaram, A. New antituberculous drugs in development. Curr HIV/AIDS Rep 2010, 7(3): 143-51.
3. Kalscheuer, R., Syson, K., Veeraraghavan, U. et al. Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway. Nat Chem Biol 2010, 6(5): 376-84.
4. Murphy, H.N., Stewart, G.R., Mischenko, V.V. et al. The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem 2005, 280(15): 14524-9.
5. Arguelles, J.C. Physiological roles of trehalose in bacteria and yeasts: a comparative analysis. Arch Microbiol 2000, 174(4): 217-24.
6. Bosch, A.M. Classical galactosaemia revisited. J Inherit Metab Dis 2006, 29(4): 516-25.
7. Slepak, T., Tang, M., Addo, F., Lai, K. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model. Mol Genet Metab 2005, 86(3): 360-71.
8. Yarmolinsky, M.B., Wiesmeyer, H., Kalckar, H.M., Jordan, E. Hereditary Defects in Galactose Metabolism in Escherichia Coli Mutants, Ii. Galactose-Induced Sensitivity. Proc Natl Acad Sci U S A 1959, 45(12): 1786-91.
9. Mtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci U S A 2003, 100(17): 10026-31.
10. Boshoff, H.I., Myers, T.G., Copp, B.R., McNeil, M.R., Wilson, M.A., Barry, C.E., 3rd The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 2004, 279(38): 40174-84.
11. Boshoff, H.I., Reed, M.B., Barry, C.E., 3rd, Mizrahi, V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 2003, 113(2): 183-93.
12. Barea, F., Bonatto, D. Relationships among carbohydrate intermediate metabolites and DNA damage and repair in yeast from a systems biology perspective. Mutat Res 2008, 642(1-2): 43-56.
13. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A., Collins, J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130(5): 797-810.
14. Pethe, K., Sequeira, P.C., Agarwalla, S. et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat Commun 2010, 1: 57.
15. Leistikow, R.L., Morton, R.A., Bartek, I.L., Frimpong, I., Wagner, K., Voskuil, M.I. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol 2010, 192(6): 1662-70.
16. Gengenbacher, M., Rao, S.P., Pethe, K., Dick, T. Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 2010, 156(Pt 1): 81-7.
17. Rao, S.P., Alonso, S., Rand, L., Dick, T., Pethe, K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2008, 105(33): 11945-50.
18. Tong, A.H., Lesage, G., Bader, G.D. et al. Global mapping of the yeast genetic interaction network. Science 2004, 303(5659): 808-13.
19. Boone, C., Bussey, H., Andrews, B.J. Exploring genetic interactions and networks with yeast. Nat Rev Genet 2007, 8(6): 437-49.
20. Jackson, M., Brennan, P.J. Polymethylated polysaccharides from Mycobacterium species revisited. J Biol Chem 2009, 284(4): 1949-53.
21. Tanaka, M., Machida, Y., Niu, S. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 2004, 10(2): 148-54.